Charles Schwab’s Advent Technologies ADN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-605
Closed -$10.7K 3576
2023
Q2
$10.7K Hold
605
﹤0.01% 3594
2023
Q1
$19.2K Hold
605
﹤0.01% 3511
2022
Q4
$32.9K Hold
605
﹤0.01% 3440
2022
Q3
$56K Buy
+605
New +$53.9K ﹤0.01% 3303
2022
Q2
Sell
-2,854
Closed -$199K 3539
2022
Q1
$199K Buy
2,854
+1,189
+71% +$135K ﹤0.01% 3309
2021
Q4
$351K Buy
1,665
+118
+8% +$29.4K ﹤0.01% 3254
2021
Q3
$404K Sell
1,547
-5,269
-77% -$1.28M ﹤0.01% 3204
2021
Q2
$1.97M Buy
6,816
+1,358
+25% +$452K ﹤0.01% 2719
2021
Q1
$2.19M Buy
+5,458
New +$2.47M ﹤0.01% 2636

Other funds holding ADN

Charles Schwab's ADN Position: Q3 2023 in Review

Charles Schwab sold out of Advent Technologies (ADN) in Q3 2023, closing a stake of 605 shares — an estimated $10.7K sold.

Charles Schwab first reported a position in ADN in Q1 2021 and held it in 9 quarters. The position peaked at $2.19M in Q1 2021. 35 funds tracked by Wall St. Rank hold ADN as of Q3 2023.

  • Charles Schwab reported no remaining Advent Technologies position as of Q3 2023 after selling out during the quarter.
  • Charles Schwab sold 605 Advent Technologies shares in Q3 2023, an estimated $10.7K.
  • Charles Schwab first reported a position in Advent Technologies in Q1 2021 and held it in 9 quarters.
  • Charles Schwab's Advent Technologies position peaked at $2.19M in Q1 2021.
  • 35 funds tracked by Wall St. Rank held Advent Technologies as of Q3 2023.

Based on Charles Schwab's 13F filing for Q3 2023, filed 8 Nov 2023.